🔎 Trials Near Me

Domov › Rakovina prsníka › Kalifornia › Irvine

Klinické štúdie Rakovina prsníka v meste Irvine, CA

23 štúdií pre Rakovina prsníka hľadá účastníkov v zariadeniach v meste Irvine a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.

Oficiálny text štúdie (anglicky)

Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

Prebieha náborFáza 2
  • City of Hope at Irvine Lennar, Irvine
Vek 70 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT04305834

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

Prebieha náborFáza 2
  • City of Hope at Orange County Lennar Foundation Cancer Center, Irvine
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06369285

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Prebieha náborFáza 3
  • Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine, Irvine
  • City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07174336

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

Prebieha náborFáza 2
  • City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Vek 18 a viac · Ženy · Aktualizované 22. 9. 2026 · NCT07287098

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

Prebieha náborVítaní zdravých dobrovoľníkov
  • University of California Irvine, Irvine
Vek 30 až 74 · Ženy · Aktualizované 21. 9. 2026 · NCT02620852

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Prebieha náborFáza 1/2
  • City of Hope, Irvine, Irvine
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07109726

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Prebieha náborFáza 3
  • City of Hope at Irvine Lennar, Irvine
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT06492616

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

Prebieha náborFáza 1/2
  • City of Hope - Orange County Lennar Foundation Cancer Center, Irvine
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT03424005

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

Prebieha náborFáza 1/2
  • City of Hope, Irvine
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT05315700

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Prebieha náborFáza 3
  • Hoag Hospital Center, Irvine
  • Hoag Hospital Irvine, Irvine
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT06072612

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Prebieha náborFáza 3
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • Kaiser Permanente-Irvine, Irvine
Vek 18 až 60 · Ženy · Aktualizované 2. 9. 2026 · NCT05879926

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

Prebieha nábor
  • City of Hope at Irvine Lennar, Irvine
Vek 18 a viac · Ženy · Aktualizované 10. 8. 2026 · NCT07741968

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Prebieha náborFáza 3
  • City of Hope - Orange County Lennar Foundation Cancer Center, Irvine
Vek 18 až 100 · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT05232916

E-Mindfulness Approaches for Living After Breast Cancer

Prebieha náborFáza 3
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • Kaiser Permanente-Irvine, Irvine
Vek 18 až 50 · Všetky pohlavia · Aktualizované 4. 8. 2026 · NCT06748222

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Prebieha náborFáza 3
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Vek 50 až 70 · Všetky pohlavia · Aktualizované 23. 4. 2026 · NCT04852887

Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer

Prebieha náborFáza 2
  • City of Hope at Irvine Lennar, Irvine
Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 12. 2025 · NCT06910761

Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

Prebieha náborFáza 2
  • City of Hope at Irvine Lennar, Irvine
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 12. 2025 · NCT06731894

Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer

Prebieha náborFáza 2
  • City of Hope at Irvine Lennar, Irvine
Vek 40 a viac · Ženy · Aktualizované 29. 10. 2025 · NCT06954831

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Prebieha náborObservačná štúdia
  • Massive Bio SYNERGY-AI site, Irvine
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774

Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

Prebieha náborFáza 2
  • City of Hope at Irvine Lennar, Irvine
Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 10. 2025 · NCT06260033

Štúdie Rakovina prsníka v iných mestách

Iné štúdie v Irvine

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.